Skip to main content

Abstract

Tea, a product of the leaves and buds of the Camellia sinensis (Theaceae) plant, is one of the world’s most popular beverages. Tea can be broadly classified according to the production method as unfermented (green tea), half-fermented (oolong tea), fully fermented (black tea), or post-fermented (pu-erh tea). Green tea is mainly consumed in Japan and China, whereas black tea is primarily consumed in Western countries, India, and other parts of the world. The global production of green tea accounts for only 20 % of the total amount of tea produced, which is approximately one fourth of that of black tea [1]. However, green tea has been the primary target for investigations on health and nutrition among the various teas as indicated by a search conducted in the PubMed database in January 2015, which showed approximately 6020, 3340, 330, and 100 publications for the keywords “green tea,” “black tea,” “oolong tea,” and “pu-erh tea,” respectively. When combined with cancer, for example, the corresponding numbers of publications were approximately 2000, 670, 40, and 10, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thakur VS, Gupta K, Gupta S. The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr Pharm Biotechnol. 2012;13:191–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Carlson JR, Bauer BA, Vincent A, Limburg PJ, Wilson T. Reading the tea leaves: anticarcinogenic properties of (−)-epigallocatechin-3-gallate. Mayo Clin Proc. 2007;82:725–32.

    Article  CAS  PubMed  Google Scholar 

  3. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9:429–39.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Suzuki Y, Miyoshi N, Isemura M. Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88:88–101.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81.

    Article  CAS  PubMed  Google Scholar 

  6. Weikel KA, Garber C, Baburins A, Taylor A. Nutritional modulation of cataract. Nutr Rev. 2014;72:30–47.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Sorice A, Guerriero E, Capone F, Colonna G, Castello G, Costantini S. Ascorbic acid: its role in immune system and chronic inflammation diseases. Mini Rev Med Chem. 2014;14:444–52.

    Article  CAS  PubMed  Google Scholar 

  8. Smith TJ. Green tea polyphenols in drug discovery – a success or failure? Expert Opin Drug Discov. 2011;6:589–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Shukla Y. Tea and cancer chemoprevention: a comprehensive review. Asian Pac J Cancer Prev. 2007;8:155–66.

    PubMed  Google Scholar 

  10. Chow HH, Hakim IA. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res. 2011;64:105–12.

    PubMed Central  CAS  PubMed  Google Scholar 

  11. Ishida H, Wakimoto T, Kitao Y, Tanaka S, Miyase T, Nukaya H. Quantitation of chafurosides A and B in tea leaves and isolation of prechafurosides A and B from oolong tea leaves. J Agric Food Chem. 2009;57:6779–86.

    Article  CAS  PubMed  Google Scholar 

  12. Shohin Test Hokoku (Commercial products test reports). Kochi Prefecture Consumer Center. 2000;35:1–17 (in Japanese)

    Google Scholar 

  13. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997;26:769–75.

    Article  CAS  PubMed  Google Scholar 

  14. Vogiatzoglou A, Heuer T, Mulligan AA, Lentjes MA, Luben RN, Kuhnle GG. Estimated dietary intakes and sources of flavanols in the German population (German National Nutrition Survey II). Eur J Nutr. 2014;53:635–43.

    Article  CAS  PubMed  Google Scholar 

  15. Oguni I, Nasu K, Kanaya S, Ota Y, Yamamoto S, Komura T. Epidemiological and experimental studies on the antitumor activity by green tea extracts. Jpn J Nutr. 1989;47:93–102.

    Article  Google Scholar 

  16. Tewes FJ, Koo LC, Meisgen TJ, Rylander R. Lung cancer risk and mutagenicity of tea. Environ Res. 1990;52:23–33.

    Article  CAS  PubMed  Google Scholar 

  17. Sasazuki S, Tamakoshi A, Matsuo K, et al. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2012;42:335–46.

    Article  PubMed  Google Scholar 

  18. McCann SE, Yeh M, Rodabaugh K, Moysich KB. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. Int J Cancer. 2009;124:1650–3.

    Article  CAS  PubMed  Google Scholar 

  19. Lee AH, Su D, Pasalich M, Binns CW. Tea consumption reduces ovarian cancer risk. Cancer Epidemiol. 2013;37:54–9.

    Article  CAS  PubMed  Google Scholar 

  20. Geybels MS, Verhage BA, Arts IC, van Schooten FJ, Goldbohm RA, van den Brandt PA. Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. Am J Epidemiol. 2013;177:1388–98.

    Article  PubMed  Google Scholar 

  21. Yuan JM, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res. 2011;64:123–35.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Zheng JS, Yang J, Fu YQ, Huang T, Huang YJ, Li D. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013;65:1–16.

    Article  CAS  PubMed  Google Scholar 

  23. Montague JA, Butler LM, Wu AH, et al. Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Cancer Causes Control. 2012;23:1635–41.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Tea consumption and the risk of overall and grade specific prostate cancer: a large prospective cohort study of Scottish men. Nutr Cancer. 2012;64:790–7.

    Article  CAS  PubMed  Google Scholar 

  25. Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC. Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology. 1999;54:823–8.

    Article  CAS  PubMed  Google Scholar 

  26. Yamane T. Clinical trial involving 8 patients with familial adenomatous polyposis. In: Isemura M, editor. Beneficial health effect of green tea. Kerala: Research Signpost; 2008. p. 105–12.

    Google Scholar 

  27. Shimizu M, Fukutomi Y, Ninomiya M, et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev. 2008;17:3020–5.

    Article  CAS  PubMed  Google Scholar 

  28. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66:1234–40.

    Article  CAS  PubMed  Google Scholar 

  29. Brausi M, Rizzi F, Bettuzzi S. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol. 2008;54:472–3.

    Article  PubMed  Google Scholar 

  30. Hara Y. Tea catechins and their applications as supplements and pharmaceutics. Pharmacol Res. 2011;64:100–4.

    Article  CAS  PubMed  Google Scholar 

  31. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A. 2001;98:10350–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Tachibana H. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:66–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Tsang WP, Kwok TT. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem. 2010;21:140–6.

    Article  CAS  PubMed  Google Scholar 

  34. Chakrabarti M, Ai W, Banik NL, Ray SK. Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells. Neurochem Res. 2013;38:420–32.

    Article  CAS  PubMed  Google Scholar 

  35. Pan MH, Lai CS, Wu JC, Ho CT. Epigenetic and disease targets by polyphenols. Curr Pharm Des. 2013;19:6156–85.

    Article  CAS  PubMed  Google Scholar 

  36. Hibasami H, Komiya T, Achiwa Y, et al. Black tea theaflavins induce programmed cell death in cultured human stomach cancer cells. Int J Mol Med. 1998;1:725–7.

    CAS  PubMed  Google Scholar 

  37. Halder B, Das Gupta S, Gomes A. Black tea polyphenols induce human leukemic cell cycle arrest by inhibiting Akt signaling: possible involvement of Hsp90, Wnt/beta-catenin signaling and FOXO1. FEBS J. 2012;279:2876–91.

    Article  CAS  PubMed  Google Scholar 

  38. Lahiry L, Saha B, Chakraborty J, et al. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Carcinogenesis. 2010;31:259–68.

    Article  CAS  PubMed  Google Scholar 

  39. Pan MH, Liang YC, Lin-Shiau SY, Zhu NQ, Ho CT, Lin JK. Induction of apoptosis by the oolong tea polyphenol theasinensin A through cytochrome c release and activation of caspase-9 and caspase-3 in human U937 cells. J Agric Food Chem. 2000;48:6337–46.

    Article  CAS  PubMed  Google Scholar 

  40. Chiang CT, Weng MS, Lin-Shiau SY, Kuo KL, Tsai YJ, Lin JK. Pu-erh tea supplementation suppresses fatty acid synthase expression in the rat liver through downregulating Akt and JNK signalings as demonstrated in human hepatoma HepG2 cells. Oncol Res. 2005;16:119–28.

    PubMed  Google Scholar 

  41. Wang J, Hudson R, Sintim HO. Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs. Future Med Chem. 2012;4:1113–51.

    Article  PubMed  Google Scholar 

  42. Conney AH, Lu YP, Lou YR, Kawasumi M, Nghiem P. Mechanisms of caffeine-induced inhibition of UVB carcinogenesis. Front Oncol. 2013;3:144.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Miwa S, Sugimoto N, Yamamoto N, et al. Caffeine induces apoptosis of osteosarcoma cells by inhibiting AKT/mTOR/S6K, NF-kappaB and MAPK pathways. Anticancer Res. 2012;32:3643–9.

    CAS  PubMed  Google Scholar 

  44. Suzuki Y, Isemura M. Binding interaction between (−)-epigallocatechin gallate causes impaired spreading of cancer cells on fibrinogen. Biomed Res. 2013;34:301–8.

    Article  CAS  PubMed  Google Scholar 

  45. Brown AL, Lane J, Coverly J, et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr. 2009;101:886–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Hino A, Adachi H, Enomoto M, et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 2007;76:383–9.

    Article  CAS  PubMed  Google Scholar 

  47. Takami H, Nakamoto M, Uemura H, et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima. Jpn J Epidemiol. 2013;23:12–20.

    Article  Google Scholar 

  48. Vernarelli JA, Lambert JD. Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults. Eur J Nutr. 2013;52:1039–48.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Basu A, Sanchez K, Leyva MJ, et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr. 2010;29:31–40.

    Article  CAS  PubMed  Google Scholar 

  50. Vieira Senger AE, Schwanke CH, Gomes I, Valle Gottlieb MG. Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging. 2012;16:738–42.

    Article  CAS  PubMed  Google Scholar 

  51. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity. 2007;15:1473–83.

    Article  CAS  PubMed  Google Scholar 

  52. Kubota K, Sumi S, Tojo H, et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res. 2011;31:421–8.

    Article  CAS  PubMed  Google Scholar 

  53. Yuda N, Tanaka M, Suzuki M, Asano Y, Ochi H, Iwatsuki K. Polyphenols extracted from black tea (Camellia sinensis) residue by hot-compressed water and their inhibitory effect on pancreatic lipase in vitro. J Food Sci. 2012;77:H254–61.

    Article  PubMed  Google Scholar 

  54. Grove KA, Sae-tan S, Kennett MJ, Lambert JD. (−)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity. 2012;20:2311–3.

    Article  CAS  PubMed  Google Scholar 

  55. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord. 2002;26:1459–64.

    Article  CAS  PubMed  Google Scholar 

  56. Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, Lin JK. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J. 2003;3:267–76.

    CAS  PubMed  Google Scholar 

  57. Huang HC, Lin JK. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food Funct. 2012;3:170–7.

    Article  CAS  PubMed  Google Scholar 

  58. Gardner EJ, Ruxton CH, Leeds AR. Black tea--helpful or harmful? A review of the evidence. Eur J Clin Nutr. 2007;61:3–18.

    Article  CAS  PubMed  Google Scholar 

  59. Larsson SC. Coffee, tea, and cocoa and risk of stroke. Stroke. 2014;45:309–14.

    Article  PubMed  Google Scholar 

  60. Larsson SC, Virtamo J, Wolk A. Black tea consumption and risk of stroke in women and men. Ann Epidemiol. 2013;23:157–60.

    Article  PubMed  Google Scholar 

  61. Hou Y, Shao W, Xiao R, et al. Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model. Exp Gerontol. 2009;44:434–9.

    Article  PubMed  Google Scholar 

  62. Liu G, Mi XN, Zheng XX, Xu YL, Lu J, Huang XH. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2014;112:1043–54.

    Article  CAS  PubMed  Google Scholar 

  63. Greyling A, Ras RT, Zock PL, et al. The effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trials. PLoS One. 2014;9:e103247.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006;144:554–62.

    Article  PubMed  Google Scholar 

  65. van Woudenbergh GJ, Kuijsten A, Drogan D, et al. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS One. 2012;7:e36910.

    Article  PubMed  Google Scholar 

  66. Huang H, Guo Q, Qiu C, et al. Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women. PLoS One. 2013;8:e79214.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Beresniak A, Duru G, Berger G, Bremond-Gignac D. Relationships between black tea consumption and key health indicators in the world: an ecological study. BMJ Open. 2012;2:e000648.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Maruyama K, Iso H, Sasaki S, Fukino Y. The association between concentrations of green tea and blood glucose levels. J Clin Biochem Nutr. 2009;44:41–5.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Nagao T, Meguro S, Hase T, et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity. 2009;17:310–7.

    Article  CAS  PubMed  Google Scholar 

  70. Boggs DA, Rosenberg L, Ruiz-Narvaez EA, Palmer JR. Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr. 2010;92:960–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Hayashino Y, Fukuhara S, Okamura T, Tanaka T, Ueshima H. High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study. Diabet Med. 2011;28:805–10.

    Article  CAS  PubMed  Google Scholar 

  72. Pham NM, Nanri A, Kochi T, et al. Coffee and green tea consumption is associated with insulin resistance in Japanese adults. Metabolism. 2014;63:400–8.

    Article  CAS  PubMed  Google Scholar 

  73. Oba S, Nagata C, Nakamura K, et al. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr. 2010;103:453–9.

    Article  CAS  PubMed  Google Scholar 

  74. Williamson G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res. 2013;57:48–57.

    Article  CAS  PubMed  Google Scholar 

  75. Anderson RA, Polansky MM. Tea enhances insulin activity. J Agric Food Chem. 2002;50:7182–6.

    Article  CAS  PubMed  Google Scholar 

  76. Han MK. Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med. 2003;35:136–9.

    Article  CAS  PubMed  Google Scholar 

  77. Wolfram S, Raederstorff D, Preller M, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136:2512–8.

    CAS  PubMed  Google Scholar 

  78. Abe K, Ijiri M, Suzuki T, Taguchi K, Koyama Y, Isemura M. Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed Res. 2005;26:187–92.

    Article  CAS  PubMed  Google Scholar 

  79. Bharrhan S, Koul A, Chopra K, Rishi P. Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One. 2011;6:e20635.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Cunha CA, Lira FS, Rosa Neto JC, et al. Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm. 2013;2013:635470.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Abe K, Suzuki T, Ijiri M, Koyama Y, Isemura M, Kinae N. The anti-fibrotic effect of green tea with a high catechin content in the galactosamine-injured rat liver. Biomed Res. 2007;28:43–8.

    Article  CAS  PubMed  Google Scholar 

  82. Kochi T, Shimizu M, Terakura D, et al. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Cancer Lett. 2014;342:60–9.

    Article  CAS  PubMed  Google Scholar 

  83. Sameshima Y, Ishida Y, Ono Y, Hujita M, Kuriki Y. Green tea powder enhances the safety and efficacy of interferon α-2b plus ribavirin combination therapy in chronic hepatitis C patients with a very high genotype 1 HCV load. In: Isemura M, editor. Beneficial health effect of green tea. Kerala: Research Signpost; 2008. p. 113–9.

    Google Scholar 

  84. Mandel SA, Youdim MB. In the rush for green gold: can green tea delay age-progressive brain neurodegeneration? Recent Pat CNS Drug Discov. 2012;7:205–17.

    Article  CAS  PubMed  Google Scholar 

  85. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331–41.

    Article  PubMed  Google Scholar 

  86. Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344:632–6.

    Article  CAS  PubMed  Google Scholar 

  87. Shirai T, Sato A, Chida K, et al. Epigallocatechin gallate-induced histamine release in patients with green tea-induced asthma. Ann Allergy Asthma Immunol. 1997;79:65–9.

    Article  CAS  PubMed  Google Scholar 

  88. Otera H, Tada K, Sakurai T, Hashimoto K, Ikeda A. Hypersensitivity pneumonitis associated with inhalation of catechin-rich green tea extracts. Respiration. 2011;82:388–92.

    Article  PubMed  Google Scholar 

  89. Pisters KM, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumor. J Clin Oncol. 2001;19:1830–8.

    CAS  PubMed  Google Scholar 

  90. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255–65.

    Article  CAS  PubMed  Google Scholar 

  91. Qiu L, Sautter J, Gu D. Associations between frequency of tea consumption and health and mortality: evidence from old Chinese. Br J Nutr. 2012;108:1686–97.

    Article  CAS  PubMed  Google Scholar 

  92. Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143:1299–308.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mamoru Isemura .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Suzuki, T., Miyoshi, N., Hayakawa, S., Imai, S., Isemura, M., Nakamura, Y. (2016). Health Benefits of Tea Consumption. In: Wilson, T., Temple, N. (eds) Beverage Impacts on Health and Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-23672-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23672-8_4

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-23671-1

  • Online ISBN: 978-3-319-23672-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics